New Therapeutic Approaches to the Treatment of Dyslipidemia 1: ApoC-III and ANGPTL3-Reference-Cited by-同舟云学术

New Therapeutic Approaches to the Treatment of Dyslipidemia 1: ApoC-III and ANGPTL3

Published:2023 Issue:1 Volume:12 Page:23
ISSN:2287-2892
Container-title:Journal of Lipid and Atherosclerosis
language:en
Short-container-title:J Lipid Atheroscler

Author:

Kim Ji Yoon¹^ORCID,Kim Nam Hoon¹^ORCID

Affiliation:

1. Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.

Funder

Korea University Anam Hospital

Publisher

XMLink

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://e-jla.org/pdf/10.12997/jla.2023.12.1.23

Reference71 articles.

1. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019

2. Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial

3. Coronary Heart Disease Prediction From Lipoprotein Cholesterol Levels, Triglycerides, Lipoprotein(a), Apolipoproteins A-I and B, and HDL Density Subfractions

4. Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70–100 years: a contemporary primary prevention cohort

5. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiopoietin-like Proteins and Lipoprotein Lipase: The Waltz Partners That Govern Triglyceride-Rich Lipoprotein Metabolism? Impact on Atherogenesis, Dietary Interventions, and Emerging Therapies;Journal of Clinical Medicine;2024-09-04

2. ANGPTL3 and ApoC-III inhibitors for treating hypertriglyceridemia in context: horses for courses?;Current Opinion in Lipidology;2024-02-19

3. The chylomicron saga: time to focus on postprandial metabolism;Frontiers in Endocrinology;2024-01-18

4. ICOSAPENT ETHYL AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN TYPE 2 DIABETES (NARRATIVE REVIEW);Proceeding of the Shevchenko Scientific Society. Medical Sciences;2023-12-22

5. Sugar and Dyslipidemia: A Double-Hit, Perfect Storm;Journal of Clinical Medicine;2023-08-31